Patents by Inventor Eunkyong Ko

Eunkyong Ko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for treating or preventing liver cancer
    Patent number: 10463669
    Abstract: The present application relates to a pharmaceutical composition containing compound 5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]-4-3H)-quinazolinone, and a pharmaceutically acceptable salt thereof for preventing and treating liver cancer, and the composition of the present application inhibits ROS-PI3K-AKT-TERT signal transduction, and thus can be favorably used in the treatment of a liver cell cancer, in which a protein involved in the signal transduction is overexpressed, especially, advanced liver cell cancer.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: November 5, 2019
    Assignee: Seoul National University R&DB Foundation
    Inventors: Guhung Jung, Eunkyong Ko, Yoon Jun Kim
  • Composition For Treating Or Preventing Liver Cancer
    Publication number: 20190160073
    Abstract: The present application relates to a pharmaceutical composition containing compound 5-fluoro-3-phenyl-2-[(15)-1-(7H-purin-6-ylamino)propyl]-4-3H)-quinazolinone, and a pharmaceutically acceptable salt thereof for preventing and treating liver cancer, and the composition of the present application inhibits ROS-PI3K-AKT-TERT signal transduction, and thus can be favorably used in the treatment of a liver cell cancer, in which a protein involved in the signal transduction is overexpressed, especially, advanced liver cell cancer.
    Type: Application
    Filed: February 14, 2017
    Publication date: May 30, 2019
    Inventors: Guhung Jung, Eunkyong Ko, Yoon Jun Kim